InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the full record of transactions filed by Attar Eyal C.. Director active across 1 companies, notably Aprea Therapeutics, Inc.. Aggregated, 7 reports have been logged. Total volume traded: €183k. The latest transaction was disclosed on 3 June 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€24,46032,667 shares@ €0.74880.41% mcap9.1% of flow
Common Stock
SEC:0001104659-22-068995:0·
042,900 shares0
Common Stock
SEC:0001104659-22-033390:0·
€55,70136,000 shares@ €1.54730.93% mcap20.8% of flow
Common Stock
SEC:0001104659-22-028757:0·
€63,50615,968 shares@ €3.977167.5% of flow
Common Stock
SEC:0001104659-21-117446·
€63,50615,968 shares@ €3.97711.06% mcap23.7% of flow
Common Stock
SEC:0001104659-21-117446:0·
€30,5309,032 shares@ €3.380232.5% of flow
Common Stock
SEC:0001104659-21-110595·
€30,5309,032 shares@ €3.38020.51% mcap11.4% of flow
Common Stock
SEC:0001104659-21-110595:0·
7 of 7 declarations
About Attar Eyal C.
Eyal C. Attar is a director at Aprea Therapeutics, Inc.
